Ileus in Medical Technology
RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments
...rade 3 or 4; >3% of patients) included anemia, hyponatremia, raised liver function, fatigue, stomatitis, anorexia, hyperglycemia, hypophosphatemia, ileus
About RAD 001
RAD001, an oral once-daily inhibitor of mTOR, is an investigational drug being studied in multiple tumor t...
F.D.A. Approves SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy
... contraindicated in patients with known hypersensitivity to
granisetron or to any of the components of the patch.
Granisetron may mask a progressive ileus
and/or gastric distention
caused by the underlying condition. Mild application site reactions have
occurred; remove patch if severe reactions or a gen...
New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
...is developing RELISTOR for the treatment of opioid-induced side
effects, including constipation (oral and subcutaneous formulations) and
(intravenous formulation). In the area of HIV
infection, the Company is developing the viral-entry inhibitor PRO 140, a
humanized monoclonal antibody ...
Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
formulation of RELISTOR for post-operative ileus
(POI). In this study, the
drug did not meet its pr...ation of
RELISTOR for patients with post-operative ileus
(POI) did not meet the
primary or secondary end po...utaneous and oral
formulations) and post-operative ileus
(intravenous formulation). In the
U.S., RELISTOR (...
Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
...ping methylnaltrexone for the treatment of opioid-induced
side effects, including constipation (oral and subcutaneous formulations)
and post-operative ileus
(intravenous formulation). In March 2007, the
Company submitted a New Drug Application to the United States Food and Drug
Administration for the subcu...
Tranzyme Pharma Presents Initial Phase IIa Data for its Novel
Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
Affairs. Tranzyme is developing TZP-101 as a first-in-class
gastroprokinetic agent for the treatment of severe gastroparesis
and post-operative ileus
Using scintigraphy and a standardized meal, this double blind,
randomized, four-way crossover study assessed the efficacy of three
Ileus in Medical Dictionary
is a disruption of the normal propulsive gastrointestinal motor activity from non-mechanical mechanisms . Motility disorders that result from structural abnormalities are termed mechanical bowel obstruction. Some... Ileus
commonly occurs for 24 to 72 hours after abdominal surgery,...
...festation of sinus node dysfunction is usually ... Postoperative ileus
is a common and potentially serious complication seen in the ... Typically, uncomplicated postoperative ileus
will resolve within 5 to 7 days ... Postoperative Care: Book Chapter...
...A gallstone that sticks in the common bile duct obstructs the flow of bile into the duodenum. ... This article aims to review gallstone ileus
in the literature addressing the ... Mirizzi syndrome, cholecystocholedochal fistula, and gall- stone ileus. ... Gallstones — Comprehensive o...
Ileus in Biological Technology